Cargando...

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging

In the United States, [(68)Ga]Ga-DOTA-TOC has been approved by the Food and Drug Administration (FDA) in 2019 as the first (68)Ga-radiopharmaceutical for imaging of somatostatin receptor (SSTR) positive gastroenteropancreatic neuroendocrine tumors while employing positron emission tomography (PET)....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmaceuticals (Basel)
Autores principales: Hennrich, Ute, Benešová, Martina
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151717/
https://ncbi.nlm.nih.gov/pubmed/32138377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13030038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!